1. Home
  2. BEAM vs LUNR Comparison

BEAM vs LUNR Comparison

Compare BEAM & LUNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$32.75

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$16.06

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
LUNR
Founded
2017
2013
Country
United States
United States
Employees
N/A
525
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BEAM
LUNR
Price
$32.75
$16.06
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$50.75
$22.35
AVG Volume (30 Days)
2.6M
11.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
82.31
N/A
EPS
N/A
N/A
Revenue
$24,000.00
N/A
Revenue This Year
N/A
$343.00
Revenue Next Year
$33.77
$16.81
P/E Ratio
N/A
N/A
Revenue Growth
33.33
N/A
52 Week Low
$15.60
$7.78
52 Week High
$38.26
$46.75

Technical Indicators

Market Signals
Indicator
BEAM
LUNR
Relative Strength Index (RSI) 48.29 29.91
Support Level $23.83 $15.87
Resistance Level $35.18 $22.52
Average True Range (ATR) 2.84 1.71
MACD -0.06 -0.23
Stochastic Oscillator 21.32 1.43

Price Performance

Historical Comparison
BEAM
LUNR

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

Share on Social Networks: